Healthcare and Life Science
Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments
Cambridge, UK - Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, announces that it has signed an investment agreement with its long-term partner, Children’s Tumor Foundation (CTF). Milestone-driven payments f...
Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification Cambridge, UK and Kyiv, Ukraine, 11 April 2024: Metrion Biosciences Limited, the specialist ion channel and cardiac safety screening contract research organisation (CRO) an...
Versius launches in Portugal as at Lusíadas Group hospital start surgical cases
CMR Surgical (CMR) – the global surgical robotics business, announces the introduction of its next-generation Surgical Robotic System, Versius, at Hospital Lusíadas Porto, marking the first installation of Versius in Portugal. ...
Preci and Biopredic International partner for higher performance of suspended pooled hepatocytes with extended longevity and large-scale availability
License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME studies ...
Cambridge Future Tech expands its Board with the appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading deeptech venture-builder further strengthens its unique position to cultivate innovative technologies with the addition of seasoned industry professionals ...
Have you heard about Carers Leave?
From 6 April 2024 all unpaid carers are entitled to up to a week's unpaid leave per year to look after someone with a disability or long-term illness. But don't panic! We are here to help :-) ...
Understanding and managing Interstitial Lung Disease
Interstitial lung disease (ILD) is an umbrella term used to describe a group of highly variable restrictive lung diseases, which are characterised by inflammation and pulmonary fibrosis (scarring of the lungs). These diseases primarily affect the lung interstitium, the tissue and the sp...
Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalised monitoring of solid tumor cancers with Droplet Digital PCR
Collaboration aims to grow clinical evidence supporting the use of Bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types. ...
Nxera Pharma joins the World Orphan Drug Alliance
Tokyo, Japan and Cambridge, UK, 8 April 2024 – Nxera Pharma Co. Ltd, formerly known as Sosei Group or Sosei Heptares – announces it has joined the World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare disease...
Access solutions: Reconciling potential for improved patient access with implementation realities
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical companies can play a key role in tackling this issue through innovative solutions, varying from short-term payment agreements to comp...